Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of NKTR will decline by -12.02% over the next 2 Weeks and hit $34.94 by Friday, January 23, 2026. In that time frame, NKTR's share price is expected to range between $30.94 and $38.87.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jan 23, 2026 | 29.46 | 33.67 | 37.86 |
| Jan 22, 2026 | 28.35 | 32.75 | 37.25 |
| Jan 21, 2026 | 30.39 | 34.93 | 39.13 |
| Jan 20, 2026 | 30.45 | 34.38 | 38.76 |
| Jan 19, 2026 | 31.80 | 36.00 | 40.41 |
| Jan 16, 2026 | 32.79 | 36.69 | 40.98 |
| Jan 15, 2026 | 31.76 | 35.77 | 39.89 |
| Jan 14, 2026 | 33.66 | 37.96 | 42.35 |
| Jan 13, 2026 | 33.23 | 37.40 | 41.70 |
| Jan 12, 2026 | 34.71 | 39.03 | 43.48 |
NKTR shares fell -4.17% in Friday, January 9, 2026's trading session, dropping from a previous close of $41.44 to move at $39.71. The stock demonstrated notable intraday movement (see NKTR's key stats for a full breakdown), fluctuating between $39.61 and $41.77, a +5.45% trading range. While recent weeks have seen some volatility, NKTR has managed to secure a -10.74% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 734.06K shares changing hands, 163.57K more than the previous session. This amounted to $29.15M in total market activity.
Will NKTR Continue Its Downward Trend?
According to analyst ratings and projections for NKTR, Nektar Therapeutics shares are anticipated to decrease by -4.88%, potentially reaching $37.86 per share by January 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for NKTR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the NKTR stock forecast, now is not the best time to buy NKTR stock because its current trading price is +17.94% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on NKTR covering social and institutional perspectives.
NKTR Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into NKTR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 29.79% to 37.21%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 46.00%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.24%, maintains a neutral outlook for the long term. Insights into NKTR's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Nektar Therapeutics Short-Term Forecasts
NKTR Forecast For Next 5 Days
Our algorithm anticipates Nektar Therapeutics (NKTR) stock could hit $34.32 by Jan 08, 2026. This represents a -13.57% fall from today's price, following a -1.99% change over the past five days.
NKTR Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Nektar Therapeutics (NKTR) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $30.79, which would mean a -22.46% decrease from the current price of $39.71. Projections for this period range from a high of $41.88 to a low of $22.94.
NKTR Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Nektar Therapeutics's price over the next three months point to a rise. NKTR stock is expected to peak at $54.67 on Mar 20, 2026 after potentially dipping to $35.50 on Jan 26, 2026. On average, NKTR is likely to trade around $46.46 in the coming 90 days.
Nektar Therapeutics Stock Forecast 2025
Based on our predictive models, Nektar Therapeutics (NKTR) is expected to trade between $35.15 and $67.93 throughout 2026. This would result in an average price of $50.35, potentially offering investors a +26.79% return from current levels.
Nektar Therapeutics Monthly Forecast 2026
January 2026
According to our latest forecast models, Nektar Therapeutics (NKTR) is positioned to show a strong performance in January 2026. The price is predicted to move between $35.15 and $48.35, settling at an average of $41.78. This could translate to a +5.21% gain.
February 2026
Based on current market signals, Nektar Therapeutics is projected to trend february 2026. We forecast a trading range from $39.11 to $54.33, with a likely average price of $47.17. Investors could expect a potential return of +18.79%.
March 2026
Our predictive algorithms indicate Nektar Therapeutics stock may see a shift in March 2026. The expected range spans $41.13–$54.67, with an average target of $48.07. This represents a positive outlook and a possible gain of +21.05%.
April 2026
Analyzing established trends, Nektar Therapeutics looks set to move in April 2026. Projections place the stock between $42.76 and $56.64, averaging around $49.46. This suggests a +24.55% gain from current levels.
May 2026
Market indicators suggest Nektar Therapeutics could experience notable changes during May 2026. Prices could fluctuate within $41.75 to $56.86, with a midpoint forecast of $49.32. The stock might deliver a +24.20% gain.
June 2026
Forecasting for June 2026, models estimate that Nektar Therapeutics may undergo key fluctuations. If trends hold, the stock might trade between $39.26 and $52.89, averaging $46.40. This signals a positive trajectory with potential returns around +16.85%.
July 2026
According to our latest forecast models, Nektar Therapeutics (NKTR) is positioned to show a strong performance in July 2026. The price is predicted to move between $42.77 and $58.95, settling at an average of $51.83. This could translate to a +30.52% gain.
August 2026
Based on current market signals, Nektar Therapeutics is projected to trend august 2026. We forecast a trading range from $45.70 to $59.16, with a likely average price of $52.74. Investors could expect a potential return of +32.81%.
September 2026
Our predictive algorithms indicate Nektar Therapeutics stock may see a shift in September 2026. The expected range spans $47.51–$61.15, with an average target of $54.20. This represents a positive outlook and a possible gain of +36.49%.
October 2026
Analyzing established trends, Nektar Therapeutics looks set to move in October 2026. Projections place the stock between $45.05 and $67.53, averaging around $53.82. This suggests a +35.53% gain from current levels.
November 2026
Market indicators suggest Nektar Therapeutics could experience notable changes during November 2026. Prices could fluctuate within $44.24 to $67.93, with a midpoint forecast of $51.80. The stock might deliver a +30.45% gain.
December 2026
Forecasting for December 2026, models estimate that Nektar Therapeutics may undergo key fluctuations. If trends hold, the stock might trade between $49.98 and $62.99, averaging $56.74. This signals a positive trajectory with potential returns around +42.89%.
NKTR's history of dividends and stock splits also plays a role in long-term investor confidence.

